oleic acid has been researched along with olmesartan medoxomil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Beg, S; Jain, S; Katare, OP; Sharma, G; Singh, B; Thanki, K | 1 |
| Bandopadhyay, S; Beg, S; Katare, OP; Saini, S; Singh, B | 1 |
3 other study(ies) available for oleic acid and olmesartan medoxomil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Positively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: Systematic development, in vitro, ex vivo and in vivo evaluation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cell Survival; Drug Liberation; Emulsions; Ethylene Glycols; Humans; Intestinal Mucosa; Intestines; Oleic Acid; Olmesartan Medoxomil; Polysorbates; Rats, Wistar | 2015 |
QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
Topics: Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Liberation; Emulsions; Lipids; Nanostructures; Oleic Acid; Olmesartan Medoxomil; Particle Size; Polysorbates; Solubility; Stearic Acids; Surface-Active Agents | 2018 |